{
    "symbol": "PRPH",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-13 14:22:06",
    "content": " Before we begin today's call, I want to advise everyone that today's conference call will contain forward-looking statements, including statements relating to our plans, expectations, future performance and future events, including statements regarding projected financial results for the second quarter of 2022, our expectations regarding the COVID-19 pandemic, future waves of the pandemic and continued demand for diagnostic testing, purse of funding; our plans to grow our diagnostic business, and expand our lab services, and our plans to grow our genomics businesses, build a WGS library and attract academic institutions, and our plans to develop a broad spectrum anti-viral OTC dietary supplement, and build a pharmaceutical division, and our expectations regarding the sufficiency of our cash or working capital."
}